Supernus Pharmaceuticals, Inc. (SUPN)
50.01
-0.25
(-0.50%)
USD |
NASDAQ |
Jan 16, 13:57
Supernus Pharmaceuticals SG&A Expense (TTM): 442.58M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amphastar Pharmaceuticals, Inc. | 126.42M |
| BridgeBio Pharma, Inc. | 467.92M |
| Catalyst Pharmaceuticals, Inc. | 162.44M |
| Assembly Biosciences, Inc. | 18.80M |
| Viking Therapeutics, Inc. | 52.36M |